Demand growth, market share gains for Thyrocare Technologies

Stock one of the top picks among analysts in health care space

With regulatory and pricing pressures for top generic drug companies on the rise, resulting in sharp drop in stock prices, brokerages are looking at companies in the health care space which have better growth opportunities. Among the high-growth segments within the health care universe is the diagnostic space; and the top pick within this is Thyrocare Technologies. Unlike the drug majors which are expecting revenue growth in low single-digit, analysts expect Thyrocare’s revenue to grow 23 per cent annually and profits by 26 per cent over FY17-19. 

One major trigger would be the potential for market share gains for organised players,